Cite
HARVARD Citation
Qiu, S. et al. (n.d.). A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection – first announcement of the protocol. Expert opinion on biological therapy. pp. 133-137. [Online].